8th Annual DDR Inhibitors Summit

Loading Events
  • This event has passed.

January 28 - January 30

AstraZeneca and Merck are at the forefront of DDR inhibitor development, focusing on next-generation PARP inhibitors and innovative combination therapies. At the same time, Roche and Novartis are pushing their own DDR-targeting pipelines, exploring emerging targets such as USP1 and WRN – these combined efforts are making DDR inhibitor drug development an increasingly dynamic and transformative area.

Details

Start:
January 28
End:
January 30
Website:
https://ddr-inhibitors-summit.com/
email me
10x Medical Device Conference
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.